Amgen Holds Key to New Cancer Target as Competition Heats Up

(Bloomberg) -- A new cancer drug from Amgen Inc. has grabbed the market’s attention as the bellwether biotech company looks to replace aging blockbuster medicines.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.